Long-term antiarrhythmic drug treatment after atrial fibrillation ablation: does a too obstinate rhythm control strategy bring serious risk of proarrhythmia to ablated patients?

Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):117-118. doi: 10.1093/ehjcvp/pvy043.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Arrhythmia Agents / administration & dosage*
  • Anti-Arrhythmia Agents / adverse effects
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / therapy*
  • Catheter Ablation* / adverse effects
  • Drug Administration Schedule
  • Heart Conduction System / drug effects*
  • Heart Conduction System / physiopathology
  • Heart Conduction System / surgery*
  • Heart Rate / drug effects*
  • Humans
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents